Surgical Oncology
Volume 18, Issue 4 , Pages 366-378, December 2009

Gene expression profiling: Decoding breast cancer

  • Femke de Snoo

      Affiliations

    • Department of Medical Affairs, Agendia BV, Science Park 406, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 462 1561; fax: +31 20 462 1505.
  • ,
  • Richard Bender

      Affiliations

    • Department of Medical Affairs, Agendia Inc, Huntington Beach, CA, USA
  • ,
  • Annuska Glas

      Affiliations

    • Department of Research and Development, Agendia BV, Science Park 406, Amsterdam, The Netherlands
  • ,
  • Emiel Rutgers

      Affiliations

    • Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Accepted 24 July 2009.

Abstract 

Gene expression assays that are used in daily clinical practice for treating early breast cancer patients have been introduced in the clinic only recently. This review discusses the development of these arrays, summarizes the validation of those that are commercially available and indicates how the information provided by these assays can help in the care of patients. The review also provides an extensive overview of commercially available assays focusing on MammaPrint, the first and only assay for breast cancer management that has been cleared by the FDA.

Keywords: Breast cancer, Gene expression, Prognosis, Prediction, Multigene assay, Personalized medicine, Genetic profile, Therapy response

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0960-7404(09)00080-2

doi:10.1016/j.suronc.2009.07.005

Surgical Oncology
Volume 18, Issue 4 , Pages 366-378, December 2009